Molecular Templates, Inc.MTEM
| Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|
| Cash and cash equivalents | 6 | 11 | 7 | 8 | 10 | 11 | 59 | 88 | 85 | 25 | 25 | 32 | 12 |
|---|
| Marketable Securities Current | 14 | 60 | 117 | 50 | 39 | 13 | - | 10 | 40 | 69 | 118 | 58 | - |
|---|
| Prepaid expenses | - | - | - | - | - | - | 1 | 2 | 2 | 6 | 4 | 3 | 2 |
|---|
| Grants revenue receivable | - | - | - | - | - | - | - | - | 7 | - | - | - | 0 |
|---|
| Other current assets | - | - | - | - | - | - | 0 | 4 | 0 | 1 | 1 | 4 | 3 |
|---|
| Total current assets | 21 | 88 | 86 | 67 | 53 | 24 | 60 | 105 | 140 | 101 | 148 | 68 | 17 |
|---|
| Operating Lease Right Of Use Asset | - | - | - | - | - | - | - | - | 10 | 11 | 9 | 11 | 9 |
|---|
| Property and equipment, net | 1 | 1 | 1 | 1 | 0 | 0 | 2 | 7 | 18 | 22 | 19 | 15 | 7 |
|---|
| Other assets | 1 | 1 | 1 | 1 | 0 | - | 1 | 2 | 5 | 5 | 7 | 3 | 2 |
|---|
| Total assets | 22 | 90 | 104 | 68 | 54 | 24 | 90 | 140 | 174 | 140 | 192 | 98 | 35 |
|---|
| Accounts payable | 2 | 1 | 2 | 2 | 1 | 1 | 3 | 1 | 1 | 2 | 2 | 1 | 2 |
|---|
| Accrued liabilities | 2 | 2 | 3 | 3 | 3 | 1 | 3 | 5 | 15 | 13 | 10 | 9 | 4 |
|---|
| Deferred revenue, current | - | 9 | 15 | 15 | - | - | 3 | 26 | 17 | 14 | 33 | 46 | 9 |
|---|
| Other current liabilities | - | - | - | - | - | - | 0 | 0 | 3 | 2 | 3 | 2 | 2 |
|---|
| Total current liabilities | 9 | 17 | 27 | 26 | 11 | 3 | 10 | 33 | 36 | 38 | 47 | 57 | 17 |
|---|
| Deferred revenue, long-term | - | 53 | 77 | 62 | - | - | - | 3 | 19 | 5 | 33 | 6 | - |
|---|
| Long Term Debt Noncurrent | - | - | - | - | - | - | 1 | 3 | 3 | 15 | 35 | 36 | - |
|---|
| Operating Lease Liability Noncurrent | - | - | - | - | - | - | - | - | 12 | 12 | 10 | 12 | 10 |
|---|
| Contingent value right liability | - | - | - | - | - | - | - | - | - | - | - | - | 3 |
|---|
| Other liabilities | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 2 | 1 | 1 |
|---|
| Total liabilities | 18 | 103 | 128 | 92 | 13 | 4 | 13 | 39 | 71 | 81 | 127 | 113 | 31 |
|---|
| Commitments And Contingencies | - | - | - | - | - | - | - | - | - | - | - | - | - |
|---|
| Preferred Stock Value | - | - | - | - | - | - | - | - | - | - | - | - | - |
|---|
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Additional paid-in capital | - | - | - | - | - | - | - | - | - | - | - | - | 457 |
|---|
| Accumulated other comprehensive loss | -0 | 0 | 0 | -0 | -0 | -0 | - | - | 0 | 0 | -0 | -0 | - |
|---|
| Accumulated deficit | -252 | -323 | -352 | -373 | -329 | -354 | -64 | -95 | -164 | -269 | -352 | -445 | -453 |
|---|
| Total stockholders' equity/(deficit) | 4 | -14 | -23 | -24 | 41 | 20 | 77 | 101 | 103 | 59 | 66 | -15 | 4 |
|---|
| Total liabilities and stockholders' equity/(deficit) | 22 | 90 | 104 | 68 | 54 | 24 | 90 | 140 | 174 | 140 | 192 | 98 | 35 |
|---|